Skip to main content

Day: June 14, 2023

Quadient’s Accounts Payable and Accounts Receivable Cloud Solutions Gain Momentum Fueled by Strong Customer Adoption in the UK

Quadient’s Accounts Payable and Accounts Receivable Cloud Solutions Gain Momentum Fueled by Strong Customer Adoption in the UK Paris, June 14, 2023 Quadient (Euronext Paris: QDT), a leader in helping businesses create meaningful customer connections through digital and physical channels, today announced that its Accounts Payable (AP) and Accounts Receivable (AR) cloud solutions are experiencing strong dynamics in 2023, particularly fueled by accelerating go-to-market momentum in the UK. In the period from February, the start of Quadient’s fiscal year, through end of May, Quadient AP by Beanworks and Quadient AR by YayPay cloud solutions accounted for 27% of all Quadient’s new software customers globally, up from 20% in the same period in 2022. New customers of Quadient’s AR and AP solutions have come from a wide variety of industries—financial...

Continue reading

RIBER and IntelliEPI have qualified the MBE 8000 performance

RIBER and IntelliEPI have qualified the MBE 8000 performanceState-of-the-art laser emission resolution, 3 nm, for VCSEL applications market Extremely high thickness and doping uniformities across 8x6in or 4x8in wafers run Final qualification expected by 4th quarter for high volume optoelectronic and micro-electronic applicationsBezons (France), June 14, 2023 – 5:45pm (CET) – RIBER, the global leader for molecular beam epitaxy (MBE) equipment serving the semiconductor industry, is announcing major milestones in the joint development program with IntelliEPI for the qualification of the new MBE 8000 production platform. As the new Riber’s flagship, the MBE 8000 is the highest capacity MBE production tool available on the market, able to handle batches of eight 150 mm (6 inches) or four 200 mm (8 inches) wafers. The design of this machine...

Continue reading

Five Below, Inc. Names Kristy Chipman Chief Financial Officer and Treasurer

PHILADELPHIA, PA, June 14, 2023 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ:FIVE), the trend-right, extreme-value brand for tweens, teens and beyond, today announced that Kristy Chipman will join the Company as Chief Financial Officer and Treasurer on July 17, 2023, reporting to Joel Anderson, President and CEO. Ms. Chipman will lead the Company’s finance and accounting organization, overseeing SEC reporting and financial operations, financial planning & analysis, investor relations, internal audit, enterprise risk management, tax and treasury, and serve as the Company’s principal financial officer and principal accounting officer. Ms. Chipman succeeds Ken Bull, who, as previously announced, has assumed the new role of Chief Operating Officer of Five Below. “We are excited to welcome Kristy to the Five Below...

Continue reading

The Endoscope Revolution: Pioneering Medical Imaging

SkyQuest’s Endoscopy Equipment and Software market report provides actionable insights for individuals interested in valuable data, trends, and opportunities in a rapidly growing industry. Additionally, the report is produced and published concisely, making it accessible to various audiences, from industry experts to market readers. Finally, one can gain an in-depth understanding of the primary and secondary market drivers, providing them with a comprehensive outlook of the current market situation and future projections. Westford, USA, June 14, 2023 (GLOBE NEWSWIRE) — The global Endoscopy Equipment and Software market size is expected to reach USD 81 billion by 2030 and exhibit a CAGR of 7.5% in the forecast period (2022−2030), according to Skyquest’s latest research report. The growing prevalence of gastrointestinal...

Continue reading

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

BROOMFIELD, CO, June 14, 2023 (GLOBE NEWSWIRE) — via NewMediaWire –  Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today their commercial agreement with The Imaging Center in Grand Rapids, MI.  The Imaging Center is a new medical imaging center in the greater Grand Rapids market serving physicians who demand core imaging capabilities, as well as innovative solutions like Nociscan. “Our role in this local healthcare delivery chain is to provide the absolute best tools available to the physician customers we serve. Adding the Nociscan capability to the extensive imaging tests we currently support opens a strong marketing opportunity...

Continue reading

Farmers & Merchants Bancorp, Inc. Announces Opening of New Office in Oxford, Ohio

ARCHBOLD, Ohio, June 14, 2023 (GLOBE NEWSWIRE) — F&M Bank (“F&M), an Archbold, Ohio based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today announced its newest full-service office is now open. The new office is located at 335 South College Ave., Oxford, OH 45056. Phil Lucas, Regional President, stated: “We are excited to expand our presence in Oxford and surrounding areas. For the past three years, we have served the Oxford market through a highly productive Loan Production Office. As a community-focused financial institution, we believe our core values and relationship-based banking model meet the personal and business banking needs of Oxford. We look forward to supporting families and businesses in the greater Oxford area.” As a full-service office, F&M Bank will offer the Oxford community...

Continue reading

BRT Apartments Corp. Increases Share Repurchase Authorization To $10 Million

Declares Second Quarter 2023 Dividend GREAT NECK, N.Y., June 14, 2023 (GLOBE NEWSWIRE) — BRT APARTMENTS CORP. (NYSE:BRT), a multi-family real estate investment trust, today announced the Board of Directors has extended the term of the Company’s share repurchase program from December 31, 2023 (the “2023 Program”) to December 31, 2025 (the “2025 Program”) and increased the share repurchase authorization to up to $10 million (inclusive of the approximate $1.99 million remaining under the 2023 Program). Since announcing on May 15, 2023 that BRT may redeploy a portion of the $19.4 million in net proceeds from its recent disposition of Chatham Court and Reflections, among other things, to fund potential stock repurchases, the Company has repurchased 166,565 shares at a weighted average price of approximately $18.09 per share. The...

Continue reading

Correction: Final terms for bonds to be listed 20th June 2023

To Nasdaq Copenhagen A/S                        14th June 2023                                        Announcement no. 57/2023 CORRECTION: The following ISIN are erroneously attached to this notice: DK0009413445, DK0009413528 og DK0009413601 Final terms for bonds to be listed 20thJune 2023 On 20th June 2023, Jyske Realkredit A/S will be listing new Covered Bonds (SDO). Final terms for the bonds are attached to this announcement. The full prospectus for the Bond consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated February 21st, 2023. Jyske Realkredit’s base prospectus is available on Jyske...

Continue reading

Precipio’s Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Use of HemeScreen® technology enables diagnosis without the need for painful, invasive sampling NEW HAVEN, Conn., June 14, 2023 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen Cytopenia panel as part of the diagnostic process for molecular identification of driver mutations in a patient with a history of transfusion-dependent anemia and experiencing progressive weakness and neurological symptoms. The findings point to an underlying myeloid stem cell disorder, including a myelodysplastic syndrome and possibly a higher-grade myeloid neoplasm. A major advantage in the case work-up using the Omnia methodology was the ability to detect these driver mutations using only a peripheral blood sample and not requiring a further bone marrow biopsy to confirm pathology suspicions....

Continue reading

ZRG Expands Real Estate Practice with Acquisition of Helbling & Associates

NEW YORK and PITTSBURGH, June 14, 2023 (GLOBE NEWSWIRE) — ZRG, a rapidly growing global talent advisory firm, today announced the acquisition of Helbling & Associates, a national executive search firm focused on real estate, facilities, and construction. Helbling & Associates, based in Wexford, PA, just outside Pittsburgh, was established in 1992 by Tom Helbling to meet the recruiting needs of construction contractors and real estate developers. As clients began referring the firm to their professional networks, Helbling’s client base expanded to entities with significant real estate assets and facilities management needs. Today, Helbling’s clients include institutions of education, healthcare, and research, as well as cultural and community organizations. The group has completed search assignments in 43 states. “The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.